Total Payments
$46,522
2024 Payments
$3,801
Companies
85
Transactions
1,184
Medicare Patients
10,918
Medicare Billing
$1.2M
Payment Breakdown by Category
Research$27,244 (58.6%)
Food & Beverage$18,486 (39.7%)
Education$742.97 (1.6%)
Other$49.36 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $27,244 | 3 | 58.6% |
| Food and Beverage | $18,486 | 1,157 | 39.7% |
| Education | $742.97 | 21 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $49.36 | 3 | 0.1% |
Payments by Type
Research
$27,244
3 transactions
General
$19,278
1,181 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $22,582 | 31 | $0 (2024) |
| Eli Lilly and Company | $5,244 | 2 | $0 (2021) |
| ABBVIE INC. | $1,806 | 111 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,222 | 81 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,206 | 67 | $0 (2024) |
| Biogen, Inc. | $1,090 | 65 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $988.05 | 145 | $0 (2022) |
| PFIZER INC. | $767.05 | 48 | $0 (2024) |
| EMD Serono, Inc. | $666.98 | 32 | $0 (2024) |
| GENZYME CORPORATION | $548.28 | 30 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,801 | 164 | ABBVIE INC. ($400.77) |
| 2023 | $3,352 | 187 | ABBVIE INC. ($923.59) |
| 2022 | $3,292 | 192 | Biohaven Pharmaceutical Holding Company Ltd. ($309.86) |
| 2021 | $4,076 | 182 | Eli Lilly and Company ($1,228) |
| 2020 | $5,676 | 123 | Eli Lilly and Company ($4,016) |
| 2019 | $1,591 | 120 | EMD Serono, Inc. ($202.12) |
| 2018 | $1,445 | 119 | Supernus Pharmaceuticals, Inc. ($246.26) |
| 2017 | $23,290 | 97 | ACADIA Pharmaceuticals Inc ($22,000) |
All Payment Transactions
1,184 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: PAIN | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Neuromodulation | ||||||
| 11/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $22.76 | General |
| 11/12/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.56 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/07/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Neurology | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Lilly USA, LLC | EMGALITY (Drug), AMYVID, KISUNLA | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.26 | General |
| Category: PAIN | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Rare Disease | ||||||
| 10/16/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Neurology | ||||||
| 10/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $44.79 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACP-103-045 | ACADIA Pharmaceuticals Inc | $22,000 | 1 |
| PREVENTIVE TREATMENT OF MIGRAINE: OUTCOMES FOR PATIENTS IN REAL-WORLD HEALTHCARE SYSTEMS (TRIUMPH) | Eli Lilly and Company | $5,244 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,842 | 23,158 | $1.8M | $310,787 |
| 2022 | 26 | 2,489 | 20,868 | $1.6M | $280,047 |
| 2021 | 26 | 2,639 | 21,415 | $1.8M | $295,506 |
| 2020 | 29 | 2,948 | 26,801 | $2.0M | $319,020 |
Total Patients
10,918
Total Services
92,242
Medicare Billing
$1.2M
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 563 | 726 | $121,242 | $60,110 | 49.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 238 | 293 | $64,460 | $37,117 | 57.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 216 | 216 | $92,232 | $32,493 | 35.2% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 194 | 197 | $394,000 | $30,056 | 7.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 407 | 481 | $61,087 | $27,719 | 45.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 132 | 264 | $88,968 | $18,710 | 21.0% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 202 | 206 | $370,800 | $18,515 | 5.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 162 | 162 | $55,566 | $17,292 | 31.1% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 74 | 74 | $133,200 | $6,406 | 4.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 24 | 24 | $18,245 | $6,325 | 34.7% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 33 | 34 | $27,370 | $5,821 | 21.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 56 | 56 | $25,760 | $5,174 | 20.1% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 55 | 55 | $99,000 | $5,160 | 5.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 15 | 15 | $10,965 | $4,837 | 44.1% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 203 | 17,980 | $35,960 | $4,676 | 13.0% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 21 | 21 | $20,517 | $4,414 | 21.5% |
| 70544 | Mri scan of blood vessels of head without contrast | Office | 2023 | 38 | 38 | $38,000 | $4,246 | 11.2% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2023 | 21 | 21 | $42,000 | $3,347 | 8.0% |
| 70549 | Mri scan of blood vessels of neck before and after contrast | Office | 2023 | 13 | 13 | $26,000 | $2,582 | 9.9% |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | Office | 2023 | 25 | 2,095 | $3,666 | $2,521 | 68.8% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 22 | 47 | $8,319 | $1,960 | 23.6% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 11 | 11 | $4,620 | $1,952 | 42.2% |
| 72158 | Mri scan of lower spinal canal before and after contrast | Office | 2023 | 12 | 12 | $24,000 | $1,858 | 7.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 13 | 13 | $7,475 | $1,600 | 21.4% |
| 70547 | Mri scan of blood vessels of neck without contrast | Office | 2023 | 11 | 11 | $11,000 | $1,334 | 12.1% |
About Dr. Howard Mandell, M.D
Dr. Howard Mandell, M.D is a Neurology healthcare provider based in Rock Hill, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316939697.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Howard Mandell, M.D has received a total of $46,522 in payments from pharmaceutical and medical device companies, with $3,801 received in 2024. These payments were reported across 1,184 transactions from 85 companies. The most common payment nature is "" ($27,244).
As a Medicare-enrolled provider, Mandell has provided services to 10,918 Medicare beneficiaries, totaling 92,242 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Rock Hill, SC
- Active Since 08/22/2005
- Last Updated 04/04/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1316939697
Products in Payments
- NUPLAZID (Drug) $22,582
- KESIMPTA (Drug) $1,006
- NURTEC ODT (Drug) $794.34
- UBRELVY (Drug) $794.02
- QULIPTA (Drug) $622.31
- TROKENDI XR (Drug) $577.69
- ZEPOSIA (Drug) $535.23
- VUMERITY (Drug) $434.45
- AUBAGIO (Drug) $419.86
- NUEDEXTA (Drug) $416.01
- OXTELLAR XR (Drug) $402.42
- APTIOM (Drug) $393.37
- INGREZZA (Drug) $382.87
- Gocovri (Drug) $364.12
- TYSABRI (Biological) $332.46
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $328.35
- AUSTEDO (Drug) $302.24
- Trudhesa (Drug) $296.76
- REXULTI (Drug) $275.33
- Fycompa (Drug) $269.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Rock Hill
Harold Reeves
Neurology — Payments: $20,046
Neurology $20,046
Dr. David Buckland, D.o, D.O
Neurology — Payments: $11,758
Neurology $11,758
Dr. Saleh Alhasan, Md, MD
Neurology — Payments: $605.54
Neurology $605.54
Amanda Floyd, Md, MD
Neurology — Payments: $534.83
Neurology $534.83
Mark Porter, M.d, M.D
Neurology — Payments: $533.23
Neurology $533.23
Ryan Nelson, Do, DO
Neurology — Payments: $151.42
Neurology $151.42